Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2026-01-28 @ 3:53 PM
Study NCT ID:
NCT02094261
Status:
COMPLETED
Last Update Posted:
2024-11-06
First Post:
2014-03-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours
Sponsor:
AstraZeneca
Organization: